Conference Reports for NATAP
The International Liver Congress™
EASL - European Association for the
Study of the Liver
2019 April 10-14
Vienna Austria
Back
 
4 week treatment [G/P+/-Rbv] for hepatitis C -
a randomized controlled trial (4RIBC)
Reported by Jules Levin
EASL 219 April 10-14 Vienna